Crossmark Global Holdings, Inc.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1539204 HOUSTON, TX

Position in BMRN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$2,886,074

-$1,242,528 QoQ

Shares Held

51,090

-26.5% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Crossmark Global Holdings, Inc. holds $39,668,975 across 33 Biotechnology names. BMRN ranks #4 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	83,415	$7,851,019
2	ARGX	Argenx SE	8,668	$6,329,807
3	EXEL	Exelixis, Inc.	79,230	$3,398,174
4	BMRN	Biomarin Pharmaceutical Inc This page	51,090	$2,886,074
5	ONC	BeOne Medicines Ltd.	7,661	$2,275,087
6	ASND	Ascendis Pharma A/S	7,783	$1,780,205
7	JAZZ	Jazz Pharmaceuticals plc	6,534	$1,235,252
8	VRTX	Vertex Pharmaceuticals Inc / Ma	2,704	$1,207,444

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,886,074	51,090	-26.5%	Shares	Sole	2026-05-11
2025-12-31	$4,128,602	69,470	-6.3%	Shares	Sole	2026-02-03
2025-09-30	$4,016,397	74,158	+39.5%	Shares	Sole	2025-11-12
2025-06-30	$2,922,095	53,158	+311.2%	Shares	Sole	2025-08-08
2025-03-31	$913,951	12,929	+0.2%	Shares	Sole	2025-04-30
2024-12-31	$848,311	12,906	-3.1%	Shares	Sole	2025-01-16
2024-09-30	$936,403	13,322	+20.6%	Shares	Sole	2024-11-04
2024-06-30	$909,334	11,045	+419.0%	Shares	Sole	2024-07-29
2023-03-31	$206,926	2,128	+5.2%	Shares	Sole	2023-05-12
2022-12-31	$209,359	2,023	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.